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Introduction
Congenital heart disease is a significant source of neonatal morbidity and mortality. In liveborn infants, approximately 1/170 is diagnosed as having a structural malformation of the cardiac system. With the increased availability of good-quality prenatal ultrasonography, many of these babies are being diagnosed prior to birth, allowing for improved management and treatment.
When a congenital cardiac lesion is suspected in a newborn, physicians in multiple specialties must converge to diagnose and treat this possibly life-threatening condition. General pediatricians, neonatologists, and cardiologists are key to the immediate stabilization and care of affected children. The prognosis for a child who has a congenital cardiac malformation depends not only on the severity of the heart defect, but on whether there is an underlying syndrome present that would have implications for other medical issues or cognitive development. A careful search must be undertaken to exclude other major malformations or minor anomalies (dysmorphic features) that might lead to the diagnosis of a syndrome.
Cardiac malformations have many causes. Isolated cardiac malformations are believed to result from the interaction among multiple genes and environmental factors, known as multifactorial inheritance. In contrast, when a cardiac malformation is associated with other major malformations or minor anomalies, it is considered syndromic and can be caused by a teratogen, chromosome abnormality, or single gene disorder. Teratogenic causes include infectious etiologies (eg, rubella), chemical exposures (eg, ethanol, anticonvulsants) , and maternal conditions (eg, diabetes). Syndromes in which the neonate carries an entire extra chromosome (trisomies 13, 18, or 21) or a missing chromosome (eg, Turner syndrome) are well known to be associated with cardiac defects. Other chromosomal problems, such as cytogenetically visible deletions (eg, 11p-) or small deletions visible only by fluorescence in situ hybridization (FISH) analysis (eg, Williams syndrome, 22q11 deletion syndrome), also include cardiac malformations. In other syndromes, congenital heart malformations can be caused by mutations in single genes, such as TBX5 (Holt-Oram syndrome), JAG1 (Alagille syndrome), or ZIC3 (X-linked situs inversus). For the purposes of this review, we concentrate on relatively common disorders that have a genetic (chromosomal or single gene) basis and are associated with characteristic congenital cardiac malformations. Although no individual cardiac malformation is pathognomonic for a particular syndrome, specific cardiac anomalies often are seen in specific syndromes (Table 1) . With the assistance of a medical geneticist, the clinician who understands which cardiac malformations are associated with which syndromes and who conducts a careful dysmorphologic examination of the newborn often can make the appropriate diagnosis.
It also is important to obtain a complete family history, searching for similar or related medical issues in extended family members. A positive family history may be a clue to the diagnosis, but the absence of a family history does not exclude a genetic condition.
The identification of a syndrome that includes a cardiac malformation can have many implications. First, knowledge of other noncardiac manifestations that can occur in children who have the specific diagnosis can prompt a search for additional undiagnosed malformations. Second, an understanding of the general prognosis for children who have the specific condition can help direct the decision to proceed with surgical repair of the cardiac lesion. Third, with a specific diagnosis in hand, the family can be counseled more accurately about whether this same condition is expected to recur in future children.
The purpose of this report is to review specific cardiac malformations and the conditions that are most likely and, therefore, should be considered. Associated features for each condition are outlined, and available testing is reviewed (Table 1) . Other less specific cardiac lesions, when present, also are discussed (Table 2) .
Atrioventricular Septal Defect (AV Canal)
The atrioventricular (AV) septal defects are a group of cardiac malformations whose incidence is approximately 1/6,500 and which share defects of the AV septum and the AV valves (mitral and tricuspid). AV septal defects can be partial or complete. The complete defect is characterized by an abnormal communication between both atria and both ventricles as well as one common AV valve, reflecting incomplete separation of the AV valves. The association with which most practitioners are familiar is that of the complete AV septal defect in trisomy 21 (Down syndrome). In fact, approximately 75% of newborns who have a complete AV septal defect have Down syndrome. The clinician should look for the characteristic features of up-slanting palpebral fissures, small ears with overfolded superior helices, in-curving of the fifth fingers (clinodactyly), single transverse or bridged palmar creases, and an increased space between the first and second toes, often with an accompanying plantar crease. Approximately 40% of newborns who have trisomy 21 have cardiac malformations, and of those who have a heart defect, about 40% have a complete AV septal defect. A ventricular septal defect (VSD) is seen in 30%, atrial septal defect (ASD) in 9%, tetralogy of Fallot in 6%, and patent ductus arteriosus in 9%. It always is important to obtain routine chromosome study (karyotype) for a child who has Down syndrome because it is critical for accurate recurrence risk counseling to separate the 95% of children who have trisomy 21 due to nondisjunction from the 2% to 3% who have a Robertsonian translocation involving chromosome 21, which can be inherited from a parent.
The complete AV septal defect also can be seen in cases of situs ambiguous, and partial AV defects are found in the 22q11 deletion syndrome.
Atrial Septal Defect (ASD)
An ASD is an abnormal communication between the atria that results in shunting of blood between the two chambers. The incidence of the most common type, the secundum type atrial septal defect, is 1/2,300.
The Holt-Oram syndrome (also known as the "handheart" syndrome) should be considered in a newborn who has an ASD and defects of the upper limbs, specifically of the radial ray. The limb defects can include an absent radius or thumb, a triphalangeal thumb, or more dramatic reduction defects of the upper limb. The cardiac defects associated with Holt-Oram syndrome also can include VSDs. TBX5, the gene that causes this syndrome, is found at chromosome 12q24, but clinical testing is not available at this time.
Other genetic syndromes in which an ASD can be seen include Kabuki syndrome, Turner syndrome, trisomy 13, trisomy 21, and Noonan syndrome. 
Interrupted Aortic Arch
In this condition, there is congenital absence of a portion of the aortic arch. Type B is the most common and involves an interruption between the left carotid and the left subclavian arteries. One study found that 52% of children who had interrupted aortic arch had a microdeletion in the 22q11 region, which leads to the 22q11 deletion syndrome (also known as velocardiofacial, DiGeorge, CATCH 22, Shprintzen, or conotruncal anomalies face syndromes). This deletion syndrome is found in 1/2,000 to 4,000 live births. Affected neonates characteristically have long fingers and toes, a laterally built-up nose or bulbous nasal tip, and less commonly, cleft palate or bifid uvula (Fig.  1) . In addition, they can have aplasia or hypoplasia of the thymus or the parathyroid glands, leading to a specific T-cell immunodeficiency or hypocalcemia and subsequent seizures, respectively.
The cardiac defects found in 75% of the children who have the 22q11 deletion syndrome characteristically involve malformations of the conotruncal structures. These cardiac defects include tetralogy of Fallot, interrupted aortic arch, truncus arteriosus, and perimembranous VSDs.
Because the clinical features of this syndrome can be quite subtle, a routine karyotype and FISH study for the 22q11 deletion or a consultation with a medical geneticist should be obtained. In at least 90% of cases, the microdeletion appears as a new mutation; fewer than 10% are inherited from one of the parents.
Supravalvular Aortic Stenosis
Aortic stenosis is a left-sided outflow tract obstruction that occurs in 1/3,000 newborns. The obstruction can lead to left ventricular hypertrophy or aortic insufficiency. The supravalvular form of this condition results when the fibromembranous narrowing occurs above the aortic valve and coronary arteries.
If a newborn presents with supravalvular aortic stenosis, the diagnosis of Williams syndrome should be considered strongly. Associated features that can be seen in the neonate (Fig. 2) include periorbital fullness of subcutaneous tissues, prominent lips, long philtrum, and evidence of hypercalcemia (found in 10%).
A FISH study for a microdeletion of the 7q11 region should be ordered. Most cases of Williams syndrome are sporadic, but autosomal dominant inheritance has been reported.
Coarctation of the Aorta
Coarctation of the aorta results in a narrowing of the aortic arch (often near the level of the ductus arteriosus) and leads to increased resistance to blood flow from the proximal to distal aorta. Aortic coarctation is seen in 1/2,500 neonates.
If the child who has aortic coarctation is a female, Turner syndrome should be considered. Congenital cardiac malformations occur in 35% of newborns (and 75% of fetuses) who have Turner syndrome. The most common types of cardiac lesions are obstructive left-sided, such as aortic coarctation, aortic stenosis, bicuspid aortic valve, and hypoplastic left heart. Approximately 75% of newborns who have Turner syndrome and a cardiac defect have coarctation of the aorta. Associated features that may present in the affected neonate include a broad chest with wide-spaced nipples, puffiness of the hands and feet (Fig. 3) , and a webbed posterior neck. Routine chromosome analysis likely would show a 45,X karyotype (50%) or a 46,XX karyotype in which one of the two X chromosomes is abnormal (eg, ring, deletion) or a mosaic karyotype.
Kabuki syndrome is another condition in which aortic coarctation is a common feature. Approximately 50% of those who have Kabuki syndrome are estimated to have cardiac malformations, and 50% of those have aortic coarctation. In addition, ASDs, VSDs, partial anomalous pulmonary venous return, or valvular pulmonic stenosis can be seen. Clinically, affected children exhibit long palpebral fissures with eversion of the lower third of the eyelid, arched eyebrows, prominent ears (often with ear pits), and persistence of the fetal fingertip pads. Renal ultrasonography can reveal kidney anomalies. At this time, the genetic cause of Kabuki syndrome is unknown.
Peripheral Pulmonary Artery Stenosis
Peripheral pulmonary artery stenosis is a narrowing that obstructs blood flow from the right ventricle at the level of the pulmonary arteries. This increases resistance to flow from the right ventricle, causing right ventricular hypertrophy.
Peripheral pulmonary artery stenosis can be associated with Alagille syndrome, Noonan syndrome, Williams syndrome, or Turner syndrome. If peripheral pulmonary artery stenosis is associated with hepatic cholestasis (bile duct hypoplasia/increased direct bilirubin), Alagille syndrome should be considered. Other features of Alagille syndrome include characteristic eye findings (posterior embryotoxon), spine defects (eg, butterfly vertebrae), and characteristic facial features (eg, a broad forehead and a pointed chin). Alagille syndrome has been found to be caused by mutations in the JAG1 gene. FISH testing that can detect a microdeletion of the 20p12 region containing the JAG1 gene is available clinically, but it is only positive in approximately 7% of cases of Alagille syndrome. Additional testing is available on a research basis only.
Noonan syndrome, which occurs in 1/2,000 newborns, presents with similar clinical features to Turner syndrome, including webbed neck, a broad shieldshaped chest, and short stature. This diagnosis should be considered in a male or a female who has a normal 46,XX karyotype but a "Turner syndrome-like" phenotype. Noonan syndrome has been found to be due to autosomal dominant mutations in the PTPN11 gene (chromosome 12q24.1). Clinical testing to sequence the PTPN11 gene recently has become available and can detect mutations in approximately 50% of patients.
Hypoplastic Left Heart
In hypoplastic left heart syndrome, the left ventricle of the heart becomes so hypoplastic that it has great difficulty maintaining systemic blood flow. The right ventricle is dilated and hypertrophied, and an ASD is present. The entire systemic output is dependent on flow through the large ductus arteriosus. Often aortic or mitral valve atresia or stenosis is present, with hypoplasia of the ascending aorta.
This devastating condition can be seen in female infants who have Turner syndrome, which should prompt the clinician to look for the previously mentioned features of this syndrome. Another chromosomal abnormality that can be seen with this cardiac malformation is 11q-(Jacobsen syndrome). Accordingly, routine chromosome analysis should be undertaken in infants who present with hypoplastic left heart syndrome. Clinical findings in the neonate may include intrauterine growth retardation, widely spaced eyes, a triangular skull shape with a prowlike forehead, and a large mouth held in an open position.
Dextrocardia
Dextrocardia indicates that the heart is located in the right chest, and this finding can be seen in syndromes in which there are defects of normal body right-left symmetry. The finding also may be associated with situs abnormalities of the visceral organs. Approximately 20% to 25% of individuals who have complete situs inversus (all left/right anatomic structures in a mirror-image reversal) have Kartagener syndrome (immotile cilia syndrome). Later in life, affected children show evidence of recurrent pulmonary infections, chronic sinusitis, and male infertility (due to sperm immobility). Because this leads to a mirror-image heart, the incidence of serious cardiac malformations is low. Kartagener syndrome is caused by a defect in one component of the dynein arm. Mutations in the gene encoding axonemal dynein intermediate chain (DNAI1) at chromosome position 9p21-p13 can cause this autosomal recessive phenotype. It likely will be discovered that mutations in other similar genes also can cause the Kartagener syndrome phenotype. Currently, the diagnosis is established with a biopsy of nasal mucosa to assess ciliary function.
The other types of laterality defects present with situs ambiguous (left/right anatomic structures are discordant in their positioning), bilateral "right-sidedness" leading to asplenia, or bilateral "left-sidedness" leading to polysplenia. Affected children have a high incidence of serious complex cardiac defects. An X-linked form of this condition has been described, with mutations found in the ZIC3 gene at Xq25. Mutations have been found in other autosomal genes as well, including lefty and nodal. Clinical testing is not yet available.
Conclusions
Although congenital cardiac malformations typically are sporadic, it is important to identify those cases in which the cardiac finding is part of a syndrome. Without knowing the specific cause of the cardiac lesion, a general recurrence risk of 3% to 4% is quoted if healthy parents have one affected child, and fetal echocardiography is recommended in subsequent pregnancies. A more accurate assessment of risk can be determined if a specific diagnosis is made.
A genetics evaluation is most appropriate in neonates who have congenital cardiac malformations associated with dysmorphic features. A chromosomal analysis may be indicated, and for certain cardiac lesions, more specific testing is required. A FISH test to rule out the 22q11 deletion is particularly important for conotruncal heart lesions. In the newborn who has supravalvular aortic stenosis, a FISH test to exclude a deletion of the 7q11.23 region responsible for Williams syndrome may be needed. As more scientific information is gained, the causes of additional genetic disorders involving cardiac defects will be discovered. When these tests become clinically available, clinicians will have an increased ability to diagnose infants who have various cardiac malformation syndromes.
